cyanocobalamin semaglutide injection / Semaglutide / Cyanocobalamin Injection |
Description
- Add flexibility without increasing overall cost
Semaglutide, a glucagon-like peptide-1 receptor agonist, may be associated with increased risk of a rare eye condition, results from a large-scale retrospective study have suggested
Outcomes including any change in body weight, appetite, or metabolic markers vary from patient to patient
All of these unanswered questions only add to the urgency of determining who is most likely to benefit from GLP-1s. : Luliia Burmistrova / Getty
Weight management (and the treatment of weight-related comorbidities) is not one-size-fits-all
